Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-16-012769
Filing Date
2016-04-25
Accepted
2016-04-25 16:15:51
Documents
8
Period of Report
2016-04-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k042516_canfitebiopharma.htm 6-K 25573
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL GENERAL MEETING f6k042516ex99i_canfite.htm EX-99.1 80875
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S SPECIAL f6k042516ex99ii_canfite.htm EX-99.2 12036
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH f6k042516ex99iii_canfite.htm EX-99.3 964
5 PROXY CARD FOR HOLDERS OF SERIES 11WARRANTS WITH RESPECT TO THE COMPANY'S SPECIA f6k042516ex99iv_canfite.htm EX-99.4 12732
6 GRAPHIC image_001.jpg GRAPHIC 4212
7 GRAPHIC card1.jpg GRAPHIC 118401
8 GRAPHIC card2.jpg GRAPHIC 140094
  Complete submission text file 0001213900-16-012769.txt   495420
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 161589197
SIC: 2834 Pharmaceutical Preparations